Features & Compatibility
Tirzepatide is a modified peptide that acts as a dual agonist of the GIP and GLP-1 receptors. Its dual-receptor profile makes it a valuable compound for laboratory research involving metabolic signaling, glucose-dependent pathways, glucagon regulation, energy balance, and related biological mechanisms.
Tirzepatide provides researchers with a useful reference for studying the interaction between GIP and GLP-1 pathways in controlled laboratory environments. FDA reference
Variants:
5mg10vials | 10mg10vials | 15mg10vials | 20mg10vials | 30mg10vials | 40mg10vials | 50mg10vials | 60mg10vials | 100mg10vials | 120mg10vials
For laboratory research use only. Not intended for human consumption or therapeutic use.
Customer Reviews
Related Products
Cardiogen
Cardiogen is a short synthetic tetrapeptide composed of Alanine, Glutamic Acid, Aspartic Acid and Arginine (Ala-Glu-Asp-Arg), abbreviated as AEDR. It
Glow
Glow is a three-component research peptide blend combining BPC-157, GHK-Cu and TB-500. The formula is designed for laboratory studies involving
Retatrutide
Retatrutide, also known as LY3437943, is an investigational peptide designed to act on three metabolic hormone receptors: GIP, GLP-1, and
Semaglutide
Semaglutide is a GLP-1 analogue and GLP-1 receptor agonist that selectively binds to and activates GLP-1 receptors. It is widely
Semax
Semax is a synthetic heptapeptide composed of an ACTH (4–7) fragment combined with the Pro-Gly-Pro (PGP) sequence. It is studied
TB500(Thymosin B4 Acetate)
TB-500 is a synthetic research peptide related to Thymosin Beta-4, a naturally occurring actin-binding peptide involved in cellular organization and

Reviews
There are no reviews yet.